# Nasdaq's Wild Microcap Split Showdown! Newsy: Bud Fox's 3 Controversial Stocks of the Day Published: 2026-06-26T14:01:00.205Z Source: https://newsyai.com/edition/5047b6fd-12a9-4fa4-82ad-514c10d64f67 Archive: https://newsyai.com/newsy/bde0e0f6-7fac-4abb-93a8-996b5464e3e9.md --- **Nasdaq's Microcap Split Circus: GIBO, NUWE & INLF Edition!**[[1]](https://www.briefing.com/calendars/splits) Futures mixed (Dow flat, Nasdaq riding AI/chip rotation and Iran deal vibes), crude still sky-high. Post-holiday hangover? Markets are pure chaos with low-float squeezes, fresh reverse-split desperation, deficiency letters, and dilution daggers flying. New Nasdaq/NYSE rules are tightening the reverse-split noose on serial offenders. Yesterday’s NAMI/VRAX/RUBI limp-dicks left stains; today’s drama features fresh meat chasing $1 bids amid governance ghosts and thin-float retail frenzy. Bulls scream “listing saved, moonshot reloaded”; bears howl “next equity gangbang, sub-penny doom!” Balls-deep into three fresh volatility kings.[[2]](https://www.nasdaq.com/market-activity/stock-splits) ### 1) GIBO Holdings Limited (GIBO): “1-for-25 Reverse-Split Stiffy vs. Holding Company Hype & Serial Split Hangover” **Why it’s loud** Brutal 1-for-25 reverse split effective June 29, 2026, to chase Nasdaq bid-price compliance. Holding company play with retail sniffing “post-split bounce + restructuring narrative”; bears flag repeated split vibes, thin fundamentals, and compliance theater.[[3]](https://www.investing.com/news/company-news/gibo-holdings-announces-25for1-reverse-stock-split-93CH-4758128) **Bull case (compliance cock rocket redux)** Thin float + split to $1+ bid + narrative oxygen = parabolic rebound to $4–12+. Ape the listing save and stiffy! **Bear case (dilution rape & split limp encore)** Insane 25:1 ratio screams desperation, heavy overhang + past declines = sub-$0.40 bust. Short the limp before the next notice! **My take, first principles (real compliance signal vs. capital-structure cancer)** Legitimate bid-price fix provides short-term breathing room in a hot low-float environment, but the nuclear ratio and microcap thinness scream unsustainable structures under the new tighter Nasdaq rules. Real compliance play with real dilution risk. Scalp the spunk? **$0.35–2.80**, **$1.10C** volume stiffy—**P$0.28** fade. ### 2) Nuwellis, Inc. (NUWE): “1-for-35 Reverse-Split Hype vs. Medical Device Dreams & Nasdaq Exception Ghosts” **Why it’s loud** 1-for-35 reverse split effective June 26, 2026 (split-adjusted trading starts today), amid Nasdaq compliance push and medical device/fluid management pipeline. Retail chase potential—bulls see “post-split lift + therapeutic reset”; bears hammer execution risks, governance, and dilution ghosts.[[4]](https://www.nasdaqtrader.com/TraderNews.aspx?id=eca2026-431) **Bull case (medtech cock rocket)** Sector tailwinds (devices) + split mechanics + volume = $2–7+ rebound. Ape the fluid stiffy! **Bear case (delisting rape & burn limp)** Repeated compliance theater, thin results = sub-$0.40 crash. Short the limp before the next notice! **My take, first principles (real platform signal vs. listing cancer)** Genuine medical narrative offers narrative fuel, but microcap scale, compliance clock, and governance red flags under stricter reverse-split rules highlight classic volatility trap. Real pivot hype with real delisting risk. Scalp the spunk? **$0.25–2.20**, **$0.90C** pump—**P$0.22** fade. ### 3) INLIF Limited (INLF): “Premarket 100%+ Surge vs. Microcap Mania & Thin Float Chaos” **Why it’s loud** Explosive premarket gains (over 100% at times) on low-float retail frenzy with minimal news—classic microcap mover. Bulls chase momentum; bears flag pump-and-dump risks, no fundamentals, and dilution potential.[[5]](https://www.benzinga.com/premarket) **Bull case (squeeze cock rocket)** Thin float + retail volume + momentum = $0.15–0.80+ moonshot. Ape the squeeze stiffy! **Bear case (dump rape & limp encore)** No news, history of fades + thin results = sub-$0.05 crash. Fade the limp before the dump! **My take, first principles (real momentum signal vs. structural cancer)** Legitimate low-float fuel delivers short-term fireworks, but microcap thinness and lack of catalysts underscore unsustainable structures. Real volatility play with real fade risk. Scalp the spunk? **$0.04–0.35**, **$0.18C** hype pump—**P$0.03** fade. **Tape-Side Tactics (GIBO Split Grab, NUWE Medtech Squeeze & INLF Notice Pump – June 26 Edition)** - **GIBO**: **$0.35–2.80** compliance stiffy; **$1.10C** narrative pump, **P$0.28** dilution fade. - **NUWE**: **$0.25–2.20** medtech stiffy; **$0.90C** device pump, **P$0.22** exception fade. - **INLF**: **$0.04–0.35** squeeze stiffy; **$0.18C** retail pump, **P$0.03** fade. New split rules tightening the screws amid crude cock-up and micro-madness. Balls-deep DYOR, NFA, degens duck the dilutions! **Sources** (for tracking every claim above): - Reverse splits & reactions: NasdaqTrader.com, StockTitan, Yahoo Finance, GlobeNewswire, Investing.com (June 2026 data).[[1]](https://www.briefing.com/calendars/splits) - Nasdaq reverse-split rule changes & compliance: NasdaqTrader, SEC filings (2025-2026 updates). - Broader microcap/premarket context & volatility: Benzinga, StockAnalysis, TradingView (June 26, 2026). - Company specifics via recent filings and exchange alerts.